What is Innovative Analytics?
LBRIA operates as a full-service Contract Research Organisation (CRO), offering comprehensive support to innovators in the drug, biotech, and medical device sectors. The company specializes in crucial areas such as regulatory strategic planning, clinical trial execution, medical writing, and quality assurance. LBRIA primarily serves start-ups and small to mid-sized enterprises, leveraging its expertise in global regulatory requirements to conduct high-quality clinical studies across diverse therapeutic areas. Their services are instrumental in guiding clients from initial development phases through to market submission.
How much funding has Innovative Analytics raised?
Innovative Analytics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Innovative Analytics
PPP
Public-Private Partnership
What's next for Innovative Analytics?
The recent major strategic investment, within the context of large-scale late-stage funding, positions LBRIA for significant expansion and operational enhancement. This capital is expected to fuel further development of their service offerings, potentially broadening their reach into new therapeutic areas or geographical markets. The company is likely to focus on solidifying its market position as a key CRO partner for emerging life science companies, emphasizing efficiency and regulatory compliance in clinical trial management.
See full Innovative Analytics company page
